Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijid.2020.04.061 http://scihub22266oqcxt.onion/10.1016/j.ijid.2020.04.061 32344011!7194601!32344011     free     free     free       Int+J+Infect+Dis 2020 ; 95 (ä): 304-307 Nephropedia Template TP {{tp|p=32344011|t=2020. Mild versus severe COVID-19: Laboratory markers |pdf=|usr=}}{{32344011}} gab.com Text Mild versus severe COVID-19: Laboratory markers JO: Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32344011 #FOAvip The number of COVID-19 patients is dramatically increasing worldwide. Treatment in intensive care units (ICU) has become a major challenge; therefore, early recognition of severe forms is absolutely essential for timely triaging of patients. While the clinical status, in particular peripheral oxygen saturation (SpO2) levels, and concurrent comorbidities of COVID-19 patients largely determine the need for their admittance to ICUs, several laboratory parameters may facilitate the assessment of disease severity. Clinicians should consider low lymphocyte count as well as the serum levels of CRP, D-dimers, ferritin, cardiac troponin and IL-6, which may be used in risk stratification to predict severe and fatal COVID-19 in hospitalised patients. It is more likely that the course of the disease will be unfavourable if some or all of these parameters are altered. Twit Text FOAVip Mild versus severe COVID-19: Laboratory markers ????Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32344011 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32344011 #FOAvip English Wikipedia <ref>{{Cite pmid|32344011}}</ref> Mild versus severe COVID-19: Laboratory markers #MMPMID32344011 Velavan TP; Meyer CG Int J Infect Dis 2020[Jun]; 95 (ä): 304-307 PMID32344011show ga The number of COVID-19 patients is dramatically increasing worldwide. Treatment in intensive care units (ICU) has become a major challenge; therefore, early recognition of severe forms is absolutely essential for timely triaging of patients. While the clinical status, in particular peripheral oxygen saturation (SpO2) levels, and concurrent comorbidities of COVID-19 patients largely determine the need for their admittance to ICUs, several laboratory parameters may facilitate the assessment of disease severity. Clinicians should consider low lymphocyte count as well as the serum levels of CRP, D-dimers, ferritin, cardiac troponin and IL-6, which may be used in risk stratification to predict severe and fatal COVID-19 in hospitalised patients. It is more likely that the course of the disease will be unfavourable if some or all of these parameters are altered. |*Betacoronavirus[MESH] |Biomarkers/blood[MESH] |COVID-19[MESH] |Coronavirus Infections/blood/*diagnosis[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*diagnosis[MESH]Mild versus severe COVID-19: Laboratory markers (epmc).pdf DeepDyve Pubget Overpricing